Salipro Biotech and Top10 Japanese Pharma Company Expand Multi-Target Research Collaboration

Salipro Biotech AB today announced the expansion of its multi-target research collaboration with a Top10 Japanese pharmaceutical company. Building on our successful research program, this extended agreement includes additional drug targets and projects, leveraging our proprietary Salipro® platform technology.

The expanded collaboration will focus on a range of challenging membrane protein drug targets, such as GPCRs, ion channels and transporters. Salipro Biotech’s expertise in membrane protein stabilisation will be instrumental in advancing drug discovery programs for these targets.

We are excited to expand our research programs and to continue pushing the boundaries of drug discovery.